{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:42Z","timestamp":1707524982455},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,17]]},"DOI":"10.7759\/cureus.33858","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T09:56:02Z","timestamp":1673949362000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Myeloid Leukaemia With Translocation (8;21) Masquerading as Peripheral Blood Eosinophilia Having Dysplastic Features: A Diagnostic Challenge"],"prefix":"10.7759","author":[{"given":"Anurag","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra P","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib J","year":"2017","unstructured":"Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017, 92:1243-59. 10.1002\/ajh.24880","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.04.002","article-title":"Core binding factor acute myeloid leukemia: new prognostic categories and therapeutic opportunities","volume":"52","author":"Sinha C","year":"2015","unstructured":"Sinha C, Cunningham LC, Liu PP. Core binding factor acute myeloid leukemia: new prognostic categories and therapeutic opportunities. Semin Hematol. 2015, 52:215-22. 10.1053\/j.seminhematol.2015.04.002","journal-title":"Semin Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.187302","article-title":"Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2","volume":"103","author":"Baer C","year":"2018","unstructured":"Baer C, Muehlbacher V, Kern W, Haferlach C, Haferlach T. Molecular genetic characterization of myeloid\/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2. Haematologica. 2018, 103:e348-50. 10.3324\/haematol.2017.187302","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509075305","article-title":"AML M1 and M2 with eosinophilia and AML M4Eo: diagnostic and clinical aspects","volume":"18 Suppl 1","author":"L\u00f6ffler H","year":"1995","unstructured":"L\u00f6ffler H, Gassmann W, Haferlach T. AML M1 and M2 with eosinophilia and AML M4Eo: diagnostic and clinical aspects. Leuk Lymphoma. 1995, 18 Suppl 1:61-3. 10.3109\/10428199509075305","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of hgaematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization classification of hgaematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/104631","article-title":"Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications","volume":"2011","author":"Reikvam H","year":"2011","unstructured":"Reikvam H, Hatfield KJ, Kittang AO, Hovland R, Bruserud \u00d8. Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications. J Biomed Biotechnol. 2011, 2011:104631. 10.1155\/2011\/104631","journal-title":"J Biomed Biotechnol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2015.04.004","article-title":"Eosinophilia in hematologic disorders","volume":"35","author":"Falchi L","year":"2015","unstructured":"Falchi L, Verstovsek S. Eosinophilia in hematologic disorders. Immunol Allergy Clin North Am. 2015, 35:439-52. 10.1016\/j.iac.2015.04.004","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.03.007","article-title":"Eosinophilia in acute myeloid leukemia: Overlooked and underexamined","volume":"36","author":"Naymagon L","year":"2019","unstructured":"Naymagon L, Marcellino B, Mascarenhas J. Eosinophilia in acute myeloid leukemia: Overlooked and underexamined. Blood Rev. 2019, 36:23-31. 10.1016\/j.blre.2019.03.007","journal-title":"Blood Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198309153091103","article-title":"Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association","volume":"309","author":"Le Beau MM","year":"1983","unstructured":"Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983, 309:630-6. 10.1056\/NEJM198309153091103","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/81.6.733","article-title":"A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22)","volume":"81","author":"Bitter MA","year":"1984","unstructured":"Bitter MA, Le Beau MM, Larson RA, Rosner MC, Golomb HM, Rowley JD, Vardiman JW. A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol. 1984, 81:733-41. 10.1093\/ajcp\/81.6.733","journal-title":"Am J Clin Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2230-4","article-title":"Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21)","volume":"106","author":"Ong SY","year":"2017","unstructured":"Ong SY, Ho LP, Yeo PM, Ng HJ, Ang AL. Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21). Int J Hematol. 2017, 106:149-50. 10.1007\/s12185-017-2230-4","journal-title":"Int J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-011-0481-2","article-title":"Acute myeloid leukemia (AML-M2) with translocation (8;21) (q22;q22) and abnormal eosinophilic precursors in the bone marrow--a case report","volume":"79","author":"Gupta O","year":"2012","unstructured":"Gupta O, Aggarwal R, Prasad R. Acute myeloid leukemia (AML-M2) with translocation (8;21) (q22;q22) and abnormal eosinophilic precursors in the bone marrow--a case report. Indian J Pediatr. 2012, 79:256-9. 10.1007\/s12098-011-0481-2","journal-title":"Indian J Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijmpo.ijmpo_197_19","article-title":"An unusual case of acute myeloid leukemia with t(8:21) presenting with hypereosinophilia showing dysplastic features","volume":"41","author":"Singh P","year":"2020","unstructured":"Singh P, Aggrawal M, Dawson L, Singh A. An unusual case of acute myeloid leukemia with t(8:21) presenting with hypereosinophilia showing dysplastic features. Indian J Med Paediatr Oncol. 2020, 41:612-4. 10.4103\/ijmpo.ijmpo_197_19","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2598-x","article-title":"Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation","volume":"95","author":"Schwaab J","year":"2016","unstructured":"Schwaab J, Jawhar M, Naumann N, et al.. Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation. Ann Hematol. 2016, 95:557-62. 10.1007\/s00277-016-2598-x","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner H","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, et al.. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017, 129:424-47. 10.1182\/blood-2016-08-733196","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.129","article-title":"Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid\/lymphoid neoplasms with PDGFR rearrangements in blast phase","volume":"27","author":"Metzgeroth G","year":"2013","unstructured":"Metzgeroth G, Schwaab J, Gosenca D, et al.. Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid\/lymphoid neoplasms with PDGFR rearrangements in blast phase. Leukemia. 2013, 27:2254-6. 10.1038\/leu.2013.129","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade D","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, et al.. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010, 116:354-65. 10.1182\/blood-2009-11-254441","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.12.3767","article-title":"Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered","volume":"17","author":"Byrd JC","year":"1999","unstructured":"Byrd JC, Dodge RK, Carroll A, et al.. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol. 1999, 17:3767-75. 10.1200\/JCO.1999.17.12.3767","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131450-acute-myeloid-leukaemia-with-translocation-821-masquerading-as-peripheral-blood-eosinophilia-having-dysplastic-features-a-diagnostic-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:50Z","timestamp":1707508130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131450-acute-myeloid-leukaemia-with-translocation-821-masquerading-as-peripheral-blood-eosinophilia-having-dysplastic-features-a-diagnostic-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.33858","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}